Actuate Therapeutics, Inc. Common stock (ACTU)
US$ 8.521.79%
Price Chart
Key Statistics
Market Cap
$ 191.29M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
290.14K
52W High
$ 11.99
52W Low
$ 5.51
Dividend Yield
0.00%
Beta
0.00
Technicals
50-Day MA
8.9423
200-Day MA
8.2869
52 Week High
11.99
52 Week Low
5.51
About ACTU
Actuate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancers in the United States.
Employees
10
Headquarters
Fort Worth, TX
CEO
Mr. Daniel M. Schmitt
Latest News
Wage rise not enough for lowest-paid workers: union - Yahoo
16 hours ago • Google News
‘Significant increases’: Unions to push Labor on ‘living wage’ - The Australian
7 hours ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg